BioSpace News Archive

Steba Biotech Treats First Patient in Pivotal ENLIGHTED Study of Padeliporfin ImPACT in Low Grade Upper Tract Urothelial Cancer

Steba Biotech, the pioneering Immune Photo Activate Cancer Treatment specialist, announces the treatment of the first patient in ENLIGHTED, its pivotal Phase 3 trial of Padeliporfin ImPACT for the treatment of Low Grade Upper Tract Urothelial Cancer.

April 20, 2021
·
6 min read
XPhyto adds Top-Level Executive Talent to its Global Operations

XPhyto Therapeutics Corp. is pleased to announce the appointment of Mr. Wolfgang Probst as the Chief Operations Officer of XPhyto and the addition of Mr. Manfred Buchberger as the Head of Corporate Development at XP Diagnostics GmbH, a wholly owned German subsidiary of the Company.

April 20, 2021
·
5 min read
Genetown

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Completing the technical data set for self-declaration of a CE mark for professional use in early May, followed immediately by commercial launch in Europe

April 20, 2021
·
3 min read
Business

Axion BioSystems Announces Formation of Scientific Advisory Board

Axion BioSystems, a leading life science tools company focused on developing and commercializing label-free, bioelectronic assays used to study the function of live cells in vitro, announces the formation of a Scientific Advisory Board.

April 20, 2021
·
5 min read
Drug Development

Lecanemab (BAN2401) Phase 2b study in early Alzheimer’s disease published in peer-reviewed journal, Alzheimer’s Research & Therapy

BioArctic AB’s partner Eisai announced the publication of an article, A Randomized, Double-Blind Phase 2b Proof of Concept Clinical Trial in Early Alzheimer’s Disease with Lecanemab, an Anti-Aβ Protofibril Antibody, in the peer-reviewed journal Alzheimer’s Research & Therapy.

April 20, 2021
·
2 min read
Business

XNK Therapeutics appoints Michael Uhlin as Chief Scientific Officer

XNK Therapeutics AB announced the appointment of Professor Michael Uhlin as Chief Scientific Officer, effective August 1st.

April 20, 2021
·
3 min read
Business

Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead the clinical development of its new generation of ADCs

Tubulis announced the appointment of Günter Fingerle-Rowson, MD, PhD, as Chief Medical Officer to complement the leadership team and to further build the company’s clinical expertise.

April 20, 2021
·
3 min read
Business

QIAGEN N.V. to Report First Quarter 2021 Results

QIAGEN N.V. announced that it plans to release its report on results for the first quarter 2021 on Monday, May 3, at approximately 22:05 Central European Time / 16:05 Eastern Daylight Time.

April 20, 2021
·
2 min read
Prestige Biopharma’s New Vaccine Production Centre for Infectious Diseases Including COVID-19

Prestige Biopharma Limited, specializing in the development of antibody therapeutics, announces that the company will be introducing a vaccine development and production centre into its core business.

April 20, 2021
·
2 min read
BioMidwest

Leading US hospitals team up to promote COVID-19 vaccination

A coalition of 60 top hospitals and health care institutions have joined forces in a nationwide campaign to encourage adults to get vaccinated against COVID-19.

April 20, 2021
·
5 min read